1. Home
  2. COEP vs CYN Comparison

COEP vs CYN Comparison

Compare COEP & CYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • CYN
  • Stock Information
  • Founded
  • COEP 2017
  • CYN 2013
  • Country
  • COEP United States
  • CYN United States
  • Employees
  • COEP N/A
  • CYN N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • CYN EDP Services
  • Sector
  • COEP Health Care
  • CYN Technology
  • Exchange
  • COEP Nasdaq
  • CYN Nasdaq
  • Market Cap
  • COEP 8.1M
  • CYN 9.3M
  • IPO Year
  • COEP N/A
  • CYN 2021
  • Fundamental
  • Price
  • COEP $0.21
  • CYN $5.92
  • Analyst Decision
  • COEP
  • CYN
  • Analyst Count
  • COEP 0
  • CYN 0
  • Target Price
  • COEP N/A
  • CYN N/A
  • AVG Volume (30 Days)
  • COEP 282.8K
  • CYN 1.8M
  • Earning Date
  • COEP 11-13-2024
  • CYN 11-06-2024
  • Dividend Yield
  • COEP N/A
  • CYN N/A
  • EPS Growth
  • COEP N/A
  • CYN N/A
  • EPS
  • COEP N/A
  • CYN N/A
  • Revenue
  • COEP N/A
  • CYN $102,118.00
  • Revenue This Year
  • COEP N/A
  • CYN $18.11
  • Revenue Next Year
  • COEP N/A
  • CYN $418.19
  • P/E Ratio
  • COEP N/A
  • CYN N/A
  • Revenue Growth
  • COEP N/A
  • CYN N/A
  • 52 Week Low
  • COEP $0.15
  • CYN $2.85
  • 52 Week High
  • COEP $1.33
  • CYN $59.50
  • Technical
  • Relative Strength Index (RSI)
  • COEP 50.31
  • CYN 77.27
  • Support Level
  • COEP $0.19
  • CYN $3.41
  • Resistance Level
  • COEP $0.22
  • CYN $8.75
  • Average True Range (ATR)
  • COEP 0.02
  • CYN 0.72
  • MACD
  • COEP -0.00
  • CYN 0.37
  • Stochastic Oscillator
  • COEP 46.15
  • CYN 64.76

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About CYN Cyngn Inc.

Cyngn Inc is an industrial autonomous vehicle technology company. Its flagship innovation is DriveMod, an autonomous driving solution that can be flexibly deployed on multiple vehicle types manufactured by Original Equipment Manufacturers in various environments.

Share on Social Networks: